Cabaletta Bio, Inc.
CABA
$2.50
$0.166.84%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/3/2025
-
Seeking Alpha: Transcripts
12/3/2025
-
SeekingAlpha
11/27/2025
-
MarketBeat
11/18/2025
-
TipRanks Financial Blog
11/17/2025
-
Ticker Report
11/15/2025
-
MarketBeat
11/14/2025
-
MarketBeat
11/14/2025
-
MarketBeat
11/14/2025
-
MarketBeat
11/11/2025
-
MarketBeat
11/11/2025
-
TipRanks Financial Blog
11/10/2025
-
Ticker Report
11/10/2025
-
GuruFocus
11/10/2025
-
GuruFocus
11/10/2025
-
The Fly
11/10/2025
-
The Fly
11/10/2025
-
Globe Newswire
11/6/2025
-
MarketBeat
11/4/2025
-
Simply Wall St
11/4/2025
-
Zacks Investment Research
11/4/2025
-
GuruFocus
11/4/2025
-
Globe Newswire
11/2/2025
-
MarketBeat
11/2/2025
-
MarketBeat
11/1/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 10, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
End of March (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
267 759 3100
Address
2929 Arch Street
Philadelphia, PA 19104
Philadelphia, PA 19104
Country
Year Founded
Business Description
Sector
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. Its lead product...
more